Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135849857> ?p ?o ?g. }
- W3135849857 endingPage "584" @default.
- W3135849857 startingPage "571" @default.
- W3135849857 abstract "Abstract Background Uncontrolled hyperphosphatemia in chronic kidney disease (CKD) patients commonly results in vascular calcification leading to increased risk of cardiovascular disease. Phosphate binders (PBs) are used for hyperphosphatemia and can be calcium-based (CBPBs) or non-calcium-based (NCBPBs), the latter being more expensive than CBPBs. In this study, we used meta-analysis approaches to assess the cost-utility of PBs for hyperphosphatemia in CKD patients. Methods Relevant studies published prior to June 2019 were identified from PubMed, Scopus, the Cochrane Library, the National Health Service Economic Evaluation Database, and the Cost-Effectiveness Analysis Registry. Studies were eligible if they included CKD patients with hyperphosphatemia, compared any PBs and reported economic outcomes. Meta-analysis was applied to pool incremental net benefit (INB) across studies stratified by country income. Results A total of 25 studies encompassing 32 comparisons were eligible. Lanthanum carbonate, a NCBPB, was a more cost-effective option than CBPBs in high-income countries (HICs), with a pooled INB of $3984.4 (599.5–7369.4), especially in pre-dialysis patients and used as a second-line option with INBs of $4860.2 (641.5–9078.8), $4011.0 (533.7–7488.3), respectively. Sevelamer, also a NCBPB, was not more cost-effective as a first-line option compared to CBPBs with a pooled INB of $6045.8 (− 23,453.0 to 35,522.6) and $34,168.9 (− 638.0 to 68,975.7) in HICs and upper middle-income countries, respectively. Conclusions Lanthanum carbonate was significantly more cost-effective than CBPBs as a second-line option for hyperphosphatemia in pre-dialysis patients in HICs. However, the use of sevelamer is not more cost-effective as a first-line option compared to CBPBs." @default.
- W3135849857 created "2021-03-15" @default.
- W3135849857 creator A5000269372 @default.
- W3135849857 creator A5015689641 @default.
- W3135849857 creator A5020682446 @default.
- W3135849857 creator A5031713367 @default.
- W3135849857 creator A5038779292 @default.
- W3135849857 creator A5053331577 @default.
- W3135849857 creator A5056464791 @default.
- W3135849857 creator A5068618404 @default.
- W3135849857 date "2021-03-06" @default.
- W3135849857 modified "2023-09-25" @default.
- W3135849857 title "Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations" @default.
- W3135849857 cites W1555793538 @default.
- W3135849857 cites W1604153083 @default.
- W3135849857 cites W1646982087 @default.
- W3135849857 cites W16551212 @default.
- W3135849857 cites W1928395014 @default.
- W3135849857 cites W1968894840 @default.
- W3135849857 cites W1973914781 @default.
- W3135849857 cites W1995713863 @default.
- W3135849857 cites W2004494117 @default.
- W3135849857 cites W2007038546 @default.
- W3135849857 cites W2020071152 @default.
- W3135849857 cites W2020108550 @default.
- W3135849857 cites W2038550793 @default.
- W3135849857 cites W2042428144 @default.
- W3135849857 cites W2050587990 @default.
- W3135849857 cites W2065391462 @default.
- W3135849857 cites W2072718197 @default.
- W3135849857 cites W2073967243 @default.
- W3135849857 cites W2076944326 @default.
- W3135849857 cites W2084778838 @default.
- W3135849857 cites W2084964797 @default.
- W3135849857 cites W2086854345 @default.
- W3135849857 cites W2086861577 @default.
- W3135849857 cites W2093305027 @default.
- W3135849857 cites W2097969657 @default.
- W3135849857 cites W2103572684 @default.
- W3135849857 cites W2105831881 @default.
- W3135849857 cites W2125768513 @default.
- W3135849857 cites W2143025931 @default.
- W3135849857 cites W2145582432 @default.
- W3135849857 cites W2152876581 @default.
- W3135849857 cites W2156146595 @default.
- W3135849857 cites W2160074641 @default.
- W3135849857 cites W2161374186 @default.
- W3135849857 cites W2164878834 @default.
- W3135849857 cites W2179102356 @default.
- W3135849857 cites W2317034263 @default.
- W3135849857 cites W2343139091 @default.
- W3135849857 cites W2412754417 @default.
- W3135849857 cites W2415825867 @default.
- W3135849857 cites W2464924628 @default.
- W3135849857 cites W2465451017 @default.
- W3135849857 cites W2470481127 @default.
- W3135849857 cites W2498822622 @default.
- W3135849857 cites W2538843838 @default.
- W3135849857 cites W2592128875 @default.
- W3135849857 cites W2593744915 @default.
- W3135849857 cites W2614986146 @default.
- W3135849857 cites W2726491114 @default.
- W3135849857 cites W2738494223 @default.
- W3135849857 cites W2759895657 @default.
- W3135849857 cites W2765153777 @default.
- W3135849857 cites W2802849257 @default.
- W3135849857 cites W2890616178 @default.
- W3135849857 cites W2890669226 @default.
- W3135849857 cites W2901827147 @default.
- W3135849857 cites W2914418005 @default.
- W3135849857 cites W2921469132 @default.
- W3135849857 cites W2942961144 @default.
- W3135849857 cites W2983120099 @default.
- W3135849857 cites W3044545425 @default.
- W3135849857 cites W4245485459 @default.
- W3135849857 doi "https://doi.org/10.1007/s10198-021-01275-3" @default.
- W3135849857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8166732" @default.
- W3135849857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33677736" @default.
- W3135849857 hasPublicationYear "2021" @default.
- W3135849857 type Work @default.
- W3135849857 sameAs 3135849857 @default.
- W3135849857 citedByCount "13" @default.
- W3135849857 countsByYear W31358498572021 @default.
- W3135849857 countsByYear W31358498572022 @default.
- W3135849857 countsByYear W31358498572023 @default.
- W3135849857 crossrefType "journal-article" @default.
- W3135849857 hasAuthorship W3135849857A5000269372 @default.
- W3135849857 hasAuthorship W3135849857A5015689641 @default.
- W3135849857 hasAuthorship W3135849857A5020682446 @default.
- W3135849857 hasAuthorship W3135849857A5031713367 @default.
- W3135849857 hasAuthorship W3135849857A5038779292 @default.
- W3135849857 hasAuthorship W3135849857A5053331577 @default.
- W3135849857 hasAuthorship W3135849857A5056464791 @default.
- W3135849857 hasAuthorship W3135849857A5068618404 @default.
- W3135849857 hasBestOaLocation W31358498571 @default.
- W3135849857 hasConcept C126322002 @default.
- W3135849857 hasConcept C141071460 @default.
- W3135849857 hasConcept C177713679 @default.